Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,996 | 1,295 | 3,299 | 1,777 | 1,455 |
| Cost of Goods | 1,788 | 1,469 | 2,449 | 1,850 | 1,516 |
| Gross Profit | 208 | -174 | 850 | -73 | -61 |
| Operating Expenses | 23,188 | 23,029 | 18,448 | 19,185 | 18,539 |
| Operating Income | -22,192 | -22,734 | -17,149 | -18,408 | -18,084 |
| Other Income | 2,368 | 2,939 | 2,535 | 2,979 | 2,999 |
| Pre-tax Income | -19,824 | -19,795 | -14,614 | -15,429 | -15,085 |
| Net Income Continuous | -19,824 | -19,795 | -14,614 | -15,429 | -15,085 |
| Net Income | $-19,824 | $-19,795 | $-14,614 | $-15,429 | $-15,085 |
| EPS Basic Total Ops | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 |
| EPS Basic Continuous Ops | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 |
| EPS Diluted Total Ops | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 |
| EPS Diluted Continuous Ops | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.16 | -0.12 | -0.13 | -0.12 |
| EBITDA(a) | $-22,090 | $-22,632 | $-17,039 | $-18,294 | $-17,956 |